News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
545 Results
Type
Article (50)
Press Release (495)
Section
Business (88)
Career Advice (1)
Deals (17)
Drug Development (52)
Employer Resources (1)
FDA (19)
Job Trends (16)
News (174)
Policy (10)
Tag
Academia (7)
Allergies (1)
Alliances (26)
ALS (2)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (2)
Approvals (20)
Artificial intelligence (1)
Best Places to Work (17)
Breast cancer (1)
Cancer (6)
Career advice (1)
Cell therapy (1)
Clinical research (38)
Collaboration (6)
COVID-19 (1)
C-suite (2)
Data (5)
Diagnostics (10)
Diversity (1)
Drug discovery (2)
Earnings (28)
Employer resources (1)
Events (90)
Executive appointments (2)
FDA (22)
Funding (3)
Gene therapy (2)
GLP-1 (2)
Government (3)
Healthcare (16)
Infectious disease (2)
IPO (10)
Job creations (1)
Job search strategy (1)
Lung cancer (1)
Lymphoma (1)
Management (1)
Manufacturing (1)
MASH (3)
Medical device (7)
Medtech (7)
Mergers & acquisitions (8)
Metabolic disorders (4)
Neuropsychiatric disorders (1)
Neuroscience (5)
NextGen: Class of 2026 (1)
Non-profit (4)
Obesity (1)
Opinion (1)
Parkinson's disease (1)
Patient recruitment (1)
Peanut (1)
People (37)
Phase 1 (12)
Phase 2 (20)
Phase 3 (10)
Pipeline (7)
Postmarket research (3)
Preclinical (8)
Rare diseases (2)
Real estate (1)
Regulatory (10)
Research institute (8)
Rett syndrome (1)
Series B (1)
Startups (6)
Vaccines (6)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (33)
2026 (4)
2025 (32)
2024 (37)
2023 (39)
2022 (47)
2021 (56)
2020 (41)
2019 (66)
2018 (36)
2017 (23)
2016 (18)
2015 (22)
2014 (13)
2013 (15)
2012 (32)
2011 (18)
2010 (2)
Location
Africa (2)
Asia (12)
California (16)
China (2)
Colorado (2)
Europe (94)
Florida (1)
Kansas (1)
Massachusetts (13)
New Jersey (1)
New York (8)
North Carolina (5)
Northern California (12)
Pennsylvania (1)
South America (2)
Southern California (2)
Texas (3)
United States (51)
Utah (1)
Washington State (2)
545 Results for "mosaic".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mosaic Therapeutics Appoints Thomas Fuchs as CEO
October 21, 2025
·
2 min read
Press Releases
Mosaic Therapeutics appoints Dr Stephen Shuttleworth as Chief Scientific Officer
November 17, 2025
·
3 min read
Press Releases
Eccogene Announces First Patient Enrolled in MOSAIC Phase 2a Trial Evaluating ECC4703 and ECC0509, Individually and in Combination, for the Treatment of MASH
December 17, 2025
·
2 min read
Press Releases
Eccogene Receives U.S. FDA Clearance to Initiate Phase 2a MOSAIC Trial of ECC4703 and ECC0509 for MASH
October 6, 2025
·
2 min read
Press Releases
AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone and Royalty-Free Access to AbTherx’s Premier Human Antibody Discovery Technology
September 17, 2025
·
4 min read
Business
Mosaic Diagnostics Appoints Healthcare Industry Veteran Rob Rebak as CEO
Mosaic Diagnostics is pleased to announce the appointment of Rob Rebak as Chief Executive Officer.
June 27, 2024
·
3 min read
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
Business
Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc.
Mosaic ImmunoEngineering, Inc today announced the signing of a binding term-sheet with Oncotelic Therapeutics, Inc.
April 29, 2024
·
6 min read
BioMidwest
The Mosaic Company Unveils Mosaic Biosciences™ to Expand Offerings in Plant Health
The Mosaic Company announced the formation of the Mosaic Biosciences™ platform, a global initiative to bring the latest science and innovation to the agriculture market.
August 15, 2023
·
2 min read
Press Releases
Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies
April 24, 2025
·
3 min read
1 of 55
Next
